Judy S. Crabtree, PhD, received both a bachelor’s degree in chemistry and a doctorate in biochemistry from the University of Oklahoma. After graduating 1997, she conducted postdoctoral work in the laboratory of Dr. Francis Collins at the NIH National Human Genome Research Institute, before pursuing drug discovery for five years at Wyeth Pharmaceuticals, Research and Development in Collegeville, PA. In August 2009, she became an Assistant Professor of Genetics at LSUHSC, where her current research focuses on understanding the etiology and biological processes of endocrine tumor disorders, specifically Uterine Leiomyoma (fibroids) and Multiple Endocrine Neoplasia, Type I (MEN1). The Crabtree lab studies the role of epigenetic mechanisms in tumor formation and the role of hormones in regulating these epigenetic processes.

.

.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .